Stanford University has been a leader in facilitating the creation and development of medical technology companies. A unique relationship has existed for a number of years between academic medical center and its engineering, science, and graduate business schools. The University also benefits from its location in the heart of Silicon Valley. In recent years, the University has created a noteworthy BioDesign Innovation program focused on the process of innovating new medical technologies by integrating faculty from its various colleges and experienced medical technology entrepreneurs.
Authors Stefanos Zenios (Charles A. Holloway Professor), Josh Makower, MD (co-founder of Stanford's Biodesign Innovation Program), Paul Yock, MD (Director of the Stanford Biodesign Program and the founding Co-Chair of the Department of Bioengineering), Todd J. Brinton, MD (Clinical Assistant Professor of Medicine), Uday N. Kumar, MD (Associate Director, Curriculum of Stanford-India Biodesign), Lyn Denend (Research Associate), and Thomas M. Krummel, MD (Emile Holman Professor and Chair in the Department of Surgery, and Co-Director of the Stanford Biodesign Program)in "Biodesign" have taken the essence of the Stanford program creating a roadmap accessible to all on recognizing market opportunities, mastering the design process, and developing medical technology business know-how.
This readable and easy-to-read book includes a three-step, proven approach to the biodesign innovation process, experiences of hundreds of innovators and companies, in the form of case studies, quotes and practical advice, real-world examples, end-of-chapter projects, and Getting Started sections that will guide the reader through each of the key stages of the process and provide a template to create their own new medical devices.
Biodesign fills a big void for medical technology entrepreneurs, venture capitalists, universities, and, even, global medical technology corporations. At what may appear to be a high price for a book, "Biodesign," will, for those in medical technology innovation, prove to be a bargain.